Catrina is a postdoctoral fellow in the Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, at the University of British Columbia. She is working with Dr. Bruce Carleton, the DSEN SEARCH & PREVENT team, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) to understand how genetic variation contributes to variable responses to medication. Catrina has experience uncovering genetic causes for rare disorders from her MSc work at the University of Calgary, under the supervision of Drs. Micheil Innes and Jillian Parboosingh. She then sought to explore functional impacts of uncovered genetic mutations by pursuing a PhD under the supervision of Dr. Michel Leroux at Simon Fraser University, using the simple roundworm, C. elegans, as a model. Ultimately, Catrina’s work aims to improve the clinical care of patients by incorporating genetic predictors of both drug safety and effectiveness into predictive genetic tests that can be used by clinicians and families to assess the risks and benefits associated with specific drug treatments.